Request Deal Involvement
Elliminist Singapore completed the acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical for $100m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Osler Hoskin & Harcourt
financial advisors
Jefferies & Company
legal advisors
Latham & Watkins
or
Principals
bidder
ELLIMINIST SINGAPORE
target
NICHI-IKO (SAGENT PHARMACEUTICALS AND OMEGA LABORATORIES)
vendor
NICHI-IKO PHARMACEUTICAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite